Issue 2018/04
Nov, 2018
Dear friends and partners,
As every year we are closing our fiscal year by end of September. This is always a good opportunity for us to thank you all for contributing to DiaSys within this year but also our chance to prepare you for challenges in the next fiscal year.

Find out more
Fourth anniversary of DiaSys India
What began 2014 as an unestablished small firm with just 90 members, has risen up to stand tall amongst the IVD business leaders in India with more than 180 employees.

Find out more
Harold Rifkin Award to Dr. Viswanathan Mohan
Dr. Mohan is the chairman and chief of diabetology at the Dr. Mohan Diabetes Specialties Centre at Chennai in South India which is a WHO collaborating centre for non-communicable diseases, prevention and control. He is a pre-eminent Indian diabetologist who has a rich experience of more than 40 years in the field of diabetology. 

Find out more
InnovaStar® as part of the Carl Remigius Fresenius exhibition in the museum in Wiesbaden
On the occasion of the 200th birthday of Carl Remigius Fresenius there is a special exhibition in the museum in Wiesbaden from August 23rd 2018 until January 20th 2019 on his successful work and milestones.

Find out more
New e-mail account for QM and RA department
In order to increase transparency in the processing of your registration requests and to reduce the number of incoming CC mails, our Quality Management and Regulatory Affairs department has set up a new e-mail account to receive all registration requests in the future:

Find out more
9th Open house at DiaSys
On September 22nd 2018 the 9th „Open House“ of chemical and pharmaceutical industry in Germany took place. DiaSys, as one of many companies, invited all interested parties to glimpse behind the scenes. We offered lectures, experiments and videos to inform of our products, their development and production. Furthermore, guided tours through the production facilities were possible.

Find out more
 Experiences of oneHbA1c FS in combination with the 2-point application
Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. Hemoglobin A1c (HbA1c) is a glycated hemoglobin formed by non-enzymatic reaction of glucose with native hemoglobin. The valuable information provided by a single HbA1c test has rendered it as a reliable biomarker for the diagnosis and prognosis of diabetes.

 Find out more
 Promotional material
DiaSys' participation at AACC in Chicago
DiaSys was pleased to attend the AACC 2018 in Chicago/USA this year with more than 50.000 participants from more then 110 countries. Highlight at the DiaSys booth was the introduction of DiaSys’ respons®5H. It’s the world smallest state-of-the-art 5 part differential hematology analyzer which is equipped with many exciting features. Are you interested in learning more about DiaSys hematology? Please visit
DiaSys India at Mapcon 2018
DiaSys India successfully participated in the 39th Annual Conference of the Maharashtra Chapter of the Indian Association of Pathologists and Microbiologists (IAPM) held at the Armed Forces Medical College in Pune from the 7th - 9th of September 2018.

Please find out more
DiaSys at Medica 2018
November 12 – 15, 2018
Messe Düsseldorf
Booth No. B05, hall 07a
If you have any questions or suggestions please contact:

Executive board:
Dr. Günther Gorka,
Dr. Jan Gorka,
Peter Zöller
DiaSys Diagnostic Systems GmbH
Alte Strasse 9 | 65558 Holzheim | DE

Fon: +49 (0) 64 32 - 91 46-0
Fax: +49 (0) 64 32 - 91 46-32
Register court: AG Montabaur
Registration number: HRB 7106

Sales tax identification number according to
§ 27 a VAT registration number: DE 148-404-658